New Approach Targets Type 2’s Poorly Controlled With Metformin

Add-on of saxagliptin plus dapagliflozin shows greater improvements in glycemic control versus the use of single drug with metformin
Add-on of saxagliptin plus dapagliflozin shows greater improvements in glycemic control versus the use of single drug with metformin
Researchers found that physical exercise can elevate beta cell production by increasing the levels of growth hormone, IGF-1, glucagon-like-peptide, IL6 and IL1 receptor agonist. Exercise can also reduce the death of beta cells through decreasing pro-inflammatory agents
A new treatment for patients with type 2 diabetes could be on the horizon. Researchers recently discovered that Yohimbin, a medication that spent several years in de-registered status, is actually successful at blocking the damaging effects of gene variants that inhibit insulin production. If it becomes a clinical drug, personalized treatment may finally be available […]
A clean, well-stocked refrigerator may be the last thing you associate with better diabetes control. But it can make a bigger difference than you think. In addition to providing an efficient and functional space for healthy food and insulin storage, a spotless and organized refrigerator can keep you from getting sick. People with diabetes are […]
If you ask the average person on the street to play a word association game with diabetes, the word “fat” will come up sooner rather than later. Links between obesity and Type 2 diabetes are well established. And yet, not all fat people have diabetes, and not all people with diabetes are fat. Like many […]
A generic blood pressure medicine healed beta cells, curing diabetes in mice. Scientists are now recruiting for a human study to see if it works in people. It might heal both Type 1 and Type 2. The drug is called verapamil. It costs $4 a month at Walmart. It has been used for high blood […]
New research demonstrates a surprising relationship between artificial sweeteners, the microbes that live in your gut, and obesity and type 2 diabetes. How a series of experiments in mice and humans cleverly showed this relationship and what it means for the public.
The evidence has been piling up that properly done CT scans can help doctors find tiny lung tumors in longtime smokers while the cancer can still be treated effectively. Now Medicare is proposing to pay for annual scans for beneficiaries at a high risk for lung cancer. To qualify, patients would have to first meet […]
The decrease in sweet taste sensitivity which can lead to an increase in sugar intake might be a factor driving people with prediabetes to overt diabetes. Researchers assessed the sweet taste sensitivity in pre-diabetics in comparison with diabetics and with normoglycemic controls.
After hours of planning and anticipation, we were thrilled to see all of the hard work of the diabetes community culminate in the unprecedented patient discussion with the FDA on Nov. 3. It would not have been possible without the enormous help of the FDA staff who so generously agreed to partner with us, and […]
The app allows users to manually enter values obtained from external tracking devices, but these devices use different units of measurement to track blood sugar depending on the geographic region of the world they’re sold. For instance, the United States uses mg/dL (milligrams per decilitre), while the UK and Australia use mmol/L (millimoles per litre).
Along with gallbladder surgery and appendectomy procedures, laparoscopic gastric bypass surgery is one of the safest operations performed in America, according to a new study from the Cleveland Clinic Bariatric and Metabolic Institute.
The purpose of this study was to compare the use of a high carbohydrate, low fat diet (53% carbohydrate, 17% protein and 30% fat) to a very low carbohydrate, high unsaturated fat diet (14% carbohydrate, 28% protein and 58% fat) for their impact on glycemic control and risk factors associated with cardiovascular disease in type […]
Dexcom, maker of the popular G4 PLATINUM continuous glucometer, received FDA clearance for a new software package for the device that mimics how a natural pancreas assesses sugar levels. Software 505, as it’s called, “features the same advanced algorithm as used in artificial pancreas research around the world,” according to the company.
People who pay for Lantus might be puzzled if they hear that the company that makes the popular insulin is in trouble. In 2013, sales of Lantus earned Sanofi some $8 billion, and the drug company felt comfortable enough to raise the price of its basal insulin twice in a year.
So many people tuned in for the first-ever virtual town hall discussion between the D-Community and FDA, that the agency’s ability to livestream the three-hour meeting online slowed and eventually crashed. And it wasn’t only our diabetes dialogue… it seems the FDA’s entire network of webcast meetings shut down for a couple hours at least.
A common blood pressure drug, verapamil, was shown to completely reverse diabetes in animal models, according to research from the University of Alabama at Birmingham.
Researchers at the Harvard Stem Cell Institute have found what looks like a way (still to be proven!) to generate large quantities of human insulin-producing cells from stem cells. If developed further, this cell source could accelerate diabetes drug development and lead to game-changing therapies for type 1 and type 2 diabetes.
NovioSense, a company out of Nijmegen, Holland, has developed and just received a European patent for a tiny device that is placed in the eye to continuously measure sugar levels in tears.
The short answer is some are; some aren’t. But it’s a little more complicated than that.